April 29, 2022
PAR-21-178 - Drug Development Tools Research Grants (U01) Clinical Trial Optional
U.S. Food and Drug Administration (FDA)
This Notice is to extend the 2022 Application Due Date for PAR-21-178 titled "Drug Development Tools Research Grants (U01) Clinical Trial Optional.”
New Application Due Date(s)
May 17, 2022, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
Shashi Malhotra
Food and Drug Administration
Office of Operations, Office of Finance Budget & Acquisitions
Office of Grants and Acquisition Services
Tel: 301-402-7592
Email: Shashi.Malhotra@fda.hhs.gov
and Human Services (HHS)
